Related by context. All words. (Click for frequent words.) 60 IIIB 59 IIIb 57 IIb 57 IIIa 57 unresectable stage 57 metastatic malignant melanoma 56 completely resected 56 Stage IIIA 56 Chemoradiation 56 IIIA NSCLC 56 IV NSCLC 55 Estrogen Receptor 55 Topoisomerase 55 stage IIIB 55 Bayer HealthCare Onyx Pharmaceuticals 55 papillary renal cell carcinoma 55 CTEPH 55 biliary tract cancer 55 pT3 55 pT2 55 surgically resected 55 node dissection 55 procainamide 55 urothelial carcinoma 55 RNA Polymerase 55 Ibritumomab Tiuxetan 55 chronic thromboembolic pulmonary 54 Nebulizers 54 Hurthle cell 54 5alpha reductase 54 Stage IIB 54 Adenomas 54 IIIA 54 hepatocellular carcinomas 54 peritoneal carcinomatosis 54 surgically resectable 54 metastatic gastric 54 idarubicin 54 complement inhibitor eculizumab 54 total thyroidectomy 54 hepatorenal syndrome 54 Telatinib 54 azacytidine 54 Hormone Refractory Prostate Cancer 54 Carcinoma 54 activating mutation 54 Antibacterials 54 multidetector computed tomography 53 T1a 53 Stage IIIb 53 ^ Tc 53 Angiotensin Converting Enzyme 53 multidetector 53 esophagogastric 53 malignant ascites 53 palliative radiotherapy 53 Glioblastoma Multiforme 53 locoregional 53 nasopharyngeal carcinoma 53 Apolipoprotein 53 Hepatocellular Carcinoma HCC 53 metastatic lymph nodes 53 Soft Tissue Sarcoma 53 metastatic colorectal 53 5 fluorouracil leucovorin 53 postoperative chemotherapy 53 resectable 53 Bosentan 53 parathyroid carcinoma 53 radiotherapy RT 53 Glioma 53 artery stenosis 53 targeting miR 53 Polymerase 53 nonsmall cell lung cancer 53 Squamous Cell Carcinoma 53 Fludarabine 53 mycosis fungoides 53 Peritoneal 53 Surgical resection 53 glioblastoma GBM 53 Critical Limb Ischemia CLI 53 Leucovorin 53 Cardiac Markers 53 Cholinesterase Inhibitors 53 intraepithelial 53 Cloretazine 53 Mycophenolate Mofetil 53 neuroendocrine carcinoma 53 haematologic 52 chemoradiation therapy 52 bronchogenic carcinoma 52 dacarbazine DTIC 52 neoplasias 52 gemcitabine carboplatin 52 stage IIIA 52 Myocardial Ischemia 52 B Cell Lymphoma 52 underwent resection 52 ara C 52 CYT# potent vascular disrupting 52 Temsirolimus 52 FDG PET imaging 52 conformal radiotherapy 52 preoperative staging 52 Radioimmunotherapy 52 Tumor Response 52 Prolongs Survival 52 Chronic HCV 52 T1c 52 Epidermal Growth Factor Receptor 52 Squamous 52 tenecteplase 52 Phosphodiesterase 52 gastric adenocarcinoma 52 REUTERS Claro Cortes 52 gefitinib Iressa 52 metastatic androgen independent 52 Alkaline Phosphatase 52 recurrent glioblastoma 52 Radiofrequency Ablation RFA 52 leukemia AML 52 Enzastaurin 52 liver metastasis 52 Prospective Randomized 52 papillary RCC 52 Interferon Alfa 52 follicular lymphoma FL 52 Captopril 52 Follicular Lymphoma 52 histologic subtype 52 erlotinib Tarceva ® 52 Accuray CyberKnife 52 receptor tyrosine kinase inhibitor 52 Adjuvant Chemotherapy 52 Protein Kinase C 52 Pivotal Phase II 52 hilar 52 elevated LDH 52 Deforolimus 52 undergoing radical cystectomy 52 Intravitreal 52 K ras mutations 52 stage IIIb 52 RAS mutations 52 Metastatic breast cancer 52 Balloon Catheters 52 gadobutrol 52 pulmonary metastases 52 Class IIIb 52 Papillary 51 pediatric malignancies 51 histologies 51 Plus STAARVISC TM 51 Dose Ranging Study 51 multimodality therapy 51 Adjuvant Therapy 51 guaiac 51 recurrent NSCLC 51 AMVISC ® AMVISC ® 51 Phospholipase 51 Is Well Tolerated 51 computed tomography CT angiography 51 tumor necrosis 51 Metastatic Prostate Cancer 51 non hematologic toxicities 51 medically inoperable 51 Lymphocytic 51 Radiofrequency ablation 51 benign neoplasms 51 Human Leukocyte Antigen 51 Lymph Node 51 paclitaxel poliglumex 51 AMPLATZER R 51 myelofibrosis polycythemia vera 51 lymphadenectomy 51 nodal metastasis 51 baseline LDH 51 Pemetrexed 51 Randomized Study 51 malignant neoplasm 51 anti angiogenic agents 51 Malignant Melanoma 51 astrocytomas 51 renal artery stenting 51 Protein Kinase Inhibitors 51 histological subtype 51 including eniluracil ADH 51 Intravascular 51 Annexin 51 Disease Progression 51 Occlusive Disease 51 biliary stones 51 protein tyrosine phosphatase 51 Minimally Invasive Procedure 51 CD# CD# 51 Collagen Type 51 alpha1 51 liposomal amphotericin B 51 mildly symptomatic 51 Non Alcoholic Steatohepatitis 51 diagnosing coronary artery 51 gastric ovarian 51 demethylation agents 51 endobronchial 51 prostate carcinoma 51 assessing T DM1 51 F FDG PET 51 Myelodysplastic Syndrome MDS 51 intraepithelial neoplasia 51 kidney urologic 51 carcinoids 51 Myeloma Patients 51 ALN HPN 51 abacavir Ziagen 51 ABVD 51 Fluorouracil 51 metabotropic glutamate receptors 51 NMIBC 51 underwent surgical resection 51 Cardiotoxicity 51 Cyclophosphamide 51 HuMax EGFr 51 Trabectedin 51 unfavorable cytogenetics 51 autologous SCT 51 fluoropyrimidine 51 myelodysplastic syndrome MDS 51 hamartomas 51 Oral Fingolimod 51 Nodular 51 Esophageal 51 APACHE II 51 Astrocytoma 51 galiximab 51 PREZISTA r arm 51 p# biomarker 51 corticosteroid dexamethasone 51 histologically proven 51 Moxifloxacin 51 EBUS 51 NAVISTAR R 51 cervical carcinoma 51 armodafinil Tablets C 51 paragangliomas 51 ACE Inhibitors 51 Fracture Risk 51 metastatic neuroendocrine tumors 51 Fibrinogen 51 transthoracic 51 Vekacia R 51 Eisenmenger syndrome 50 Contrast Agent 50 Contrast Agents 50 Proxinium TM 50 otamixaban 50 grade cervical intraepithelial 50 piperacillin tazobactam 50 LHRH receptor positive 50 Xanafide 50 metastatic malignant 50 Neoadjuvant Chemotherapy 50 Chemokine Receptor 50 Nilotinib 50 Comet Assay 50 Cardiac Troponin 50 metastatic pancreatic 50 prostate cancer PCa 50 FDG-PET/CT 50 Ventricular Arrhythmias 50 proctitis 50 Immunotherapeutic 50 Valopicitabine 50 Shows Promise Against 50 MoxDuo ® 50 anaplastic astrocytomas 50 Hypertrophy 50 Cinacalcet HCl 50 Azacitidine 50 familial amyloidotic polyneuropathy FAP 50 S1 S# [001] 50 Immunohistochemical staining 50 cancer mCRC 50 chemotherapy cisplatin 50 capsular polysaccharide 50 external beam radiotherapy 50 Thrombolysis 50 Lilly Gemzar 50 relapsing remitting MS RRMS 50 adriamycin 50 Cilostazol 50 malignant lymphoma 50 resectable pancreatic cancer 50 Pooled Analysis 50 recurrent squamous cell carcinoma 50 cephalosporin antibiotics 50 Retreatment 50 DNA intercalator 50 Nodules 50 pleurodesis 50 radioiodine therapy 50 Pivotal Trial 50 HIV HCV coinfected 50 benzothiazole 50 Left Ventricular 50 T3 T4 50 #beta hydroxysteroid dehydrogenase 50 4mg/kg 50 Meets Primary Endpoint 50 Unresectable 50 CT Angiography 50 Common Toxicity Criteria 50 J Foot Ankle 50 malignant pancreatic 50 Key Attributes 50 concurrent chemoradiation 50 hormone refractory metastatic prostate 50 Cystectomy 50 oral Hycamtin 50 MKC# MT 50 Dry Powder Inhalers 50 OncoVAX ® 50 deoxy 50 segmentectomy 50 colorectal adenoma 50 Chronic Renal Failure 50 Tumor Necrosis Factor 50 Advanced Renal Cell 50 Nodule 50 EUS FNA 50 Combination Treatment 50 transrectal ultrasound guided 50 photodynamic treatment 50 Percutaneous Tibial Nerve Stimulation 50 metastatic adenocarcinoma 50 ATZ 50 BY FRANK RADOSEVICH 50 Multidrug Resistance 50 metastatic ovarian cancer 50 Interferon beta 50 anti epileptics 50 HDACi 50 Lenalidomide 50 transurethral 50 occlusion PAO 50 L#F 50 receptor blockers ARBs 50 Acute Myeloid Leukaemia AML 50 Adenoviral 50 standard chemotherapy regimens 50 IV metastatic melanoma 50 Pericardial 50 colorectal carcinoma 50 radiolabeled antibodies 50 ductal adenocarcinoma 50 diarrhea predominant irritable 50 cutaneous squamous cell carcinoma 50 amacrine 50 Mammographic 50 treat benign prostatic 50 Patients Treated With 50 benign prostatic hyperplasia enlarged 50 Sezary syndrome 50 abdominal computed tomography 50 osteosarcoma Ewing sarcoma 50 hematologic abnormalities 50 basal cell carcinoma BCC 50 confirmatory Phase 50 Secretase 50 CLL SLL 50 Renal Artery 50 docetaxel Taxotere ® 50 miRview mets 50 Cytotoxic 50 #A# #A# 50 colorectal metastases 50 paclitaxel carboplatin 50 antidiabetic drugs 50 Embolic 50 advanced medullary thyroid 50 Chronic lymphocytic leukemia 50 FLT3 50 Myocardial Infarction TIMI 50 Chronic Sinusitis 50 Hydrochlorothiazide 50 anaplastic astrocytoma 50 Raw #/#/# Punjab 50 calcineurin inhibitors 50 Leukemias 50 HepDirect prodrug 50 hormone LHRH 50 Severe Sepsis 50 Platinol ® cisplatin 50 Valvular 50 epithelial tumors 50 wedge resection 50 Stage IIIB 50 plus 5-FU/LV 50 severe oral mucositis 50 arterial embolization 50 acute peripheral arterial 50 Metastatic 50 Mucopolysaccharidosis 50 pentamidine 50 gemcitabine Gemzar ® 50 colorectal carcinomas 50 IV melanoma 50 Efficacy Trial 50 Dilated Cardiomyopathy 50 FXIII 50 Pulse Oximeters 50 MYCAMINE 50 Oropharyngeal 50 LS5 50 unfractionated heparin UFH 50 glycopeptide 50 Pralatrexate 50 unresectable tumors 50 Anaplastic 50 pancreatic carcinoma 50 bosentan Tracleer 50 intra arterial 50 Patients Undergoing 50 Anticoagulants 50 Ventilator Associated 50 endoscopic ultrasonography 50 IIIc 50 influenzae 50 MALT lymphoma 50 myelomas 50 tumors GIST 50 colorectal lung 50 Resection 50 PAOD 50 fenretinide 50 gastrointestinal GI perforation 50 Safinamide 50 Lymphoid 50 REALiS SX7 Mark 50 BENICAR HCT 50 Tigecycline 50 cytoreductive surgery 50 mucinous 50 ENGAGE AF TIMI 50 radiofrequency ablation RFA 50 Aurora Kinase 50 Xelox 49 transarterial 49 fallopian tube carcinoma 49 esophagogastroduodenoscopy 49 Secondary Hyperparathyroidism 49 NuroPro PD 49 metaplasia 49 Glioblastoma Multiforme GBM 49 Metastatic Pancreatic Cancer 49 systemic amyloidosis 49 riociguat 49 anaplastic astrocytoma AA 49 colorectal cancer liver metastases 49 efaproxiral 49 pancreatic prostate 49 EGFR HER2 49 Dehydrogenase 49 prospective multicenter study 49 debulking surgery 49 genotype 1a 49 bronchoalveolar lavage 49 immunomodulatory therapy 49 Coronary Artery Bypass Graft 49 KTP laser 49 histologically confirmed 49 Bevacizumab 49 Alphanate R 49 non nucleoside 49 Onalta TM 49 Yondelis ® 49 terlipressin 49 inotropic therapy 49 Mitomycin C 49 Cytomegalovirus CMV 49 selective antagonists 49 antisense oligonucleotide 49 thymoma 49 Trapeza CDO 49 Parathyroid Hormone 49 pancreatic adenocarcinoma 49 ZACTIMA TM ZD# 49 CsA 49 bronchial hyperresponsiveness 49 Luminal 49 GORE TAG Device 49 Janus Kinase 49 Recurrence Scores 49 duplex ultrasonography 49 multicenter randomized controlled 49 Patients Receiving 49 metastatic renal 49 ABL1 49 grade squamous intraepithelial 49 L1 L2 49 selective MHC 49 Randomized Phase 49 Factor VIIa 49 intestinal metaplasia 49 percutaneous drainage 49 GW# [003] 49 Familial Adenomatous Polyposis 49 PathFinderTG 49 Clinical Outcome 49 ZACTIMA 49 ^ sup #m 49 MoxDuo R 49 ERBB2 49 adjuvant trastuzumab 49 stereotactic radiotherapy 49 Myelodysplastic Syndromes 49 Ozarelix 49 neutropaenia 49 Myelofibrosis 49 lung fibrosis 49 TAL Advantage 49 5-FU/LV 49 Transesophageal 49 lung nodule 49 ANCA associated 49 Nucleoside 49 pulmonary hypertension PH 49 prostate abnormalities 49 Adjuvant chemotherapy 49 Arsenic trioxide 49 pulmonary alveolar 49 Pertuzumab 49 Advanced Melanoma 49 thrombocytopenic patients 49 castrate resistant 49 LymphoStat B belimumab 49 STRIDE PD 49 Motexafin Gadolinium 49 intraventricular 49 Illumina GoldenGate 49 Electrodiagnostic 49 Interferon Gamma 49 recurrent glioblastoma multiforme 49 Zollinger Ellison Syndrome 49 bisoprolol 49 Radical prostatectomy 49 Congenital Emphysema 49 FluCAM arm 49 cytologically confirmed 49 hereditary deficiency 49 HER1 49 Neuvenge 49 labial herpes 49 Randomized Phase II 49 Streptococcal 49 Brain Metastases 49 antiangiogenic agent 49 Aflibercept 49 TRAIL R1 49 aspirin clopidogrel 49 Charles L. Dimmler 49 plasmid encoding 49 serrated polyps 49 corticosteroid therapy 49 tracheal intubation 49 vWD 49 arteritis 49 vinca alkaloid 49 transthyretin amyloidosis 49 adjuvant radiotherapy 49 VATS lobectomy 49 Pivotal Phase 49 weekly subcutaneous injections 49 Malignancies 49 PEG IFN 49 Castration Resistant Prostate Cancer 49 Melphalan 49 intra arterial chemotherapy 49 International Prognostic Scoring 49 methicillin susceptible Staphylococcus aureus 49 Survival Benefit 49 Globulin 49 FOLFOX6 49 Gamma Cameras 49 GSTP1 49 HBeAg negative 49 cytidine 49 recombinant tissue plasminogen 49 schwannomas 49 benign prostatic hypertrophy BPH 49 interferon ribavirin 49 Myelodysplastic Syndrome 49 Erlotinib 49 Pelvic Organ Prolapse 49 small molecule tyrosine 49 Interferon alfa 49 adverse cytogenetics 49 LC MALDI 49 nonmetastatic 49 squamous 49 localized prostate 49 transcranial Doppler ultrasound 49 relapsed ALL 49 SSc 49 Analysers 49 Squamous Cell 49 cell lymphoma ALCL 49 pleural effusions 49 latent tuberculosis TB 49 Aortic Valve 49 BRAF V#E 49 Protease Inhibitors 49 tumor xenograft models 49 metastatic GIST 49 Metastatic Renal Cell Carcinoma 49 ergot derivatives 49 Pegylated Liposomal Doxorubicin 49 collagenous colitis 49 ACC2 49 urothelial bladder cancer 49 ß blockers 49 Lenocta 49 spondyloarthritis 49 Multicenter Study 49 Carotid 49 Peripheral Arterial 49 Metastatic Melanoma 49 Naive Patients 49 epithelial ovarian 49 calcium calmodulin dependent 49 bleomycin 49 spinal metastases 49 cardiac resynchronisation therapy 49 NS3 49 Systemic Delivery 49 variceal hemorrhage 49 Chronic lymphocytic leukemia CLL 49 Autologous Stem Cell Transplantation 49 conventional angiography 49 Autoantibodies 49 R Saizen R 49 endothelin receptor antagonists 49 Infarct 49 Immunomodulatory 49 beta lactamase inhibitor 49 Shellgel TM injectable viscoelastic 49 relapsed MM 49 Accelerated Partial Breast Irradiation 49 Recurrent Glioblastoma 49 ventilation perfusion 49 Aerosolized 49 Confirms Efficacy 49 Glycosylation 49 Antisoma Plc 49 stem cell engraftment 49 azole 49 Commences Phase 49 Csf 49 Prostatic 49 pDC 49 eIF 4E 49 p# mitogen activated 49 Elderly Patients 49 Ultrasensitive 49 Nebulizer 49 beta tubulin 49 echinocandin 49 interstitial fibrosis 49 recurrent metastatic 49 Epirubicin 49 Systemic Sclerosis 49 CIN2 + 49 Sapacitabine 49 Hepatocellular Carcinoma 49 mycophenolate 49 mediastinum 49 cytotoxic therapies 49 T2 weighted MRI 49 EDFAs 49 Hematopoietic 49 thoracolumbar spine 49 functional mitral regurgitation 49 Infusion Reactions Severe 49 ST Elevation Myocardial 49 Acute Ischemic Stroke 49 MDCT angiography 49 thalidomide Thalomid 49 Peg IFN 49 Tracheostomy 49 bevacizumab Avastin R 49 neurological manifestations 49 Anticoagulant 49 PSMA ADC 49 stage IIIb IV 49 Mitral Valve 49 vasodilators 49 SIR Spheres 49 LH RH 49 Her2 49 tonsillar 49 Sorafenib 49 chromosomal mutations 49 lung resections 49 Capecitabine 49 annexin 49 irinotecan hydrochloride 49 Fabry Disease 49 Angiogenic 49 Aneurysm Repair 49 multicenter phase 49 #m Tc 49 radical cystectomy 49 pancreatic ovarian 49 K#R [002] 49 dimeglumine 49 Tubulin 49 triiodothyronine 49 angio 49 succinate dehydrogenase 49 NPM1 mutation 49 Piazza Vittorio Emanuele 49 essential thrombocythemia ET 49 lymph node metastases 49 rhITF 49 Ischemic 49 peritumoral brain edema 49 Stomatitis 49 gastroduodenal 49 Lung Cancer Vaccine 49 neo adjuvant 49 anterior lumbar interbody fusion 49 UPPP 49 biologic DMARD 49 PIMCO Municipal Income 49 oral iclaprim 49 refractory anemia RA 49 Monotherapy 49 mCi 49 hydrolyzed collagen 49 neoplasia CIN 49 Study Evaluating 49 seminoma 48 metastatic bladder 48 Metered Dose Inhalers MDIs 48 Lobular 48 enzyme RNA polymerase 48 HER2 Positive Breast Cancer 48 NYHA Class 48 hypophosphatemia 48 gastrointestinal GI cancers 48 Medoxomil 48 Pfizer Camptosar 48 cough dyspnea 48 chronic renal disease 48 Inoperable 48 ALK inhibitors 48 Varian linear accelerators 48 phenothiazines 48 RENAL 48 Adjuvant Treatment 48 Eli Lilly Gemzar 48 ocular disorders 48 Roche LightCycler ® 48 Hypotension 48 JAK2 V#F 48 Androgen Deprivation Therapy 48 FOLFOX4 48 D Dimer 48 TheraCIM h R3 48 ureteral stents 48 Novel Oral 48 antiangiogenic agents 48 esophageal carcinoma 48 AST ALT 48 beta3 48 Relapsing Remitting Multiple Sclerosis 48 gadolinium enhanced 48 Electrophysiology EP 48 aneurysms AAA 48 deferoxamine 48 hemorrhagic cystitis 48 myofascial pain syndrome 48 Breast conserving 48 nonischemic 48 intensity modulated radiotherapy IMRT 48 Prognostic significance 48 anaplastic 48 Alveolar 48 Ventricular Tachycardia 48 Chronic Myelogenous Leukemia CML 48 HCV Genotype 48 Vorinostat 48 Fiber Optic Components 48 hyperplastic 48 saphenous vein graft 48 K#N 48 refractory chronic lymphocytic 48 endoscopic resection 48 tiuxetan 48 Cypher Stent 48 Randomized Clinical Trial 48 isoenzyme 48 lavage fluid 48 #F FDG 48 bronchoalveolar lavage BAL 48 MPGN 48 Immunohistochemical analysis 48 tuberous sclerosis TS 48 Pegylated Interferon 48 Achieves Primary Endpoint 48 recurrent colorectal cancer 48 cervical lymph nodes 48 thymidine 48 prognostic variables 48 Intra arterial 48 J Shoulder Elbow 48 TRUS 48 non hodgkin lymphoma 48 HDAC enzymes 48 Gastrointestinal Stromal Tumors 48 Stereotactic Body Radiation Therapy 48 treat chronic sinusitis 48 Antitumor 48 Novartis Femara 48 Tomographic 48 follicular lymphomas 48 RhuDex TM 48 Epratuzumab 48 PTK# 48 Spectranetics laser 48 T2 weighted images 48 gallium nitrate 48 FDG PET scans 48 DPIs 48 HER pathway 48 MR Angiography 48 #Gy 48 multicentric 48 endoluminal stent graft 48 urothelial cancer 48 mineralocorticoid receptor 48 neuroendocrine cancers 48 femoral popliteal 48 Initiate Clinical Trial 48 InfiniScale ® 48 HIPEC 48 Reductase 48 intraductal 48 non squamous 48 Replacement Therapy 48 Relapsed Refractory 48 System IPSS 48 pretargeting 48 Dasatinib 48 Diabetic Ulcers 48 Rifampicin 48 Tyrosine 48 antithrombotic therapy 48 gastrointestinal toxicities 48 antihormonal 48 B#.# [001] 48 suppl #S 48 monoclonal antibody conjugated 48 M#V 48 Antitumor Activity 48 Inhaled Corticosteroids 48 Radiofrequency Ablation 48 Intensity Modulated 48 desmoplastic 48 By PAYTON TOWNS 48 spiral computed tomography 48 Inhaled AAT 48 cefazolin 48 Renal Function 48 ChronVac C ® 48 PEGylated interferon 48 VeriStrat 48 miRview TM 48 Mesh Matrix 48 Bazedoxifene 48 Relapsed Multiple Myeloma 48 Cutaneous T 48 severe gastroparesis 48 histopathologic examination 48 IV Busulfex 48 renal tumors 48 First Patient Dosed 48 perfusion imaging 48 Atacand ® 48 aplastic anemia AA 48 NSABP B 48 H. Pylori 48 descending thoracic 48 Heart Transplant Recipients 48 Mg Usa 48 moderately emetogenic 48 electrosurgical generator 48 submandibular 48 Pharmacokinetics PK 48 metastatic hormone refractory 48 PET CT scanning 48 humanised antibody 48 GALNS 48 multi analyte 48 infiltrating ductal carcinoma 48 COPERNICUS 48 pancreatic lung 48 pleural mesothelioma 48 thymidine kinase 48 smoldering multiple myeloma 48 Coversyl 48 temsirolimus Torisel 48 CBLC# 48 Fludara ® 48 PRoFESS 48 CPVT 48 Subtypes 48 mineralocorticoid 48 Omacetaxine 48 BY RICH MCCRACKEN 48 Roche MabThera 48 Platinol ® 48 invasive carcinomas 48 endoscopic retrograde 48 Curaxin CBLC# 48 CD# antibodies 48 PET CT scans 48 ACE Inhibitor 48 cranial irradiation 48 Embolization 48 Immunosuppression 48 Viral Load 48 PROTEGE 48 post thrombotic syndrome 48 Basal Cell 48 Multidetector CT 48 Exelixis XL# 48 Pz 48 labetuzumab 48 advanced pancreatic neuroendocrine 48 pulmonary angiography 48 INFUSE Bone Graft 48 Decitabine 48 Subtype 48 Vascugel ® 48 sodium thiosulfate STS 48 KRAS mutation 48 Improves Survival 48 alpha1 antitrypsin deficiency 48 Corneal Transplant 48 miconazole Lauriad ® 48 Orally Active 48 Familial Hypercholesterolemia 48 gastroesophageal junction 48 Nebulized 48 oxacillin 48 Initiate Phase 48 Commence Phase 48 Percutaneous Transluminal Coronary Angioplasty 48 Clot Busting 48 TO AVOID PREGNANCY WHILE 48 NMDA antagonists 48 medullary thyroid carcinoma 48 Tyrosine Kinase 48 hyperparathyroidism 48 intratumoral 48 Janus kinase 48 Peginterferon Alfa 2a 48 intestinal polyps 48 refractory NSCLC 48 nitrofurantoin 48 GI bleeds 48 Fondaparinux 48 Leukotriene 48 astrocytoma 48 ER CHOP 48 Chronic Kidney 48 symptomatic benign prostatic 48 chemo immunotherapy 48 Hexvix ® 48 rosuvastatin #mg 48 pathologic examination 48 visilizumab 48 mycophenolate mofetil 48 vorinostat 48 HCV Hepatitis C 48 generation purine nucleoside 48 mRCC 48 hematologic toxicity 48 dasatinib Sprycel 48 IL2 48 Catheter Ablation 48 polyposis 48 mutated K ras 48 Enzyme Replacement Therapy 48 coagulation assays 48 Gastric Cancer 48 liver histology 48 Gemcitabine